Background: The choice between palliative chemotherapy (defined as the use of cytotoxic
medications delivered intravenously for the purpose of our study) and supportive care alone is …

Objectives Cancer may be associated with many symptoms, but pain is the one most feared
by patients. Pain is experienced by one-third of patients receiving treatment for cancer and …

The ultimate aim of our research program is to provide strategies that facilitate parental
decision-making for parents of children with cancer receiving end-of-life care. As a first step to …

In cancer care, central venous access devices (CVADs) are used to safely manage patients
undergoing long-term systemic treatment. CVADs are also used to ensure the safe delivery …

The role of the nurse practitioner has been long established in the outpatient setting in
pediatric oncology. The inpatient nurse practitioner role has been described to a lesser extent. …

Purpose Use of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in
patients unable to swallow capsules is hindered by the lack of a commercially available oral …

Purpose: Use of aprepitant in patients unable to swallow capsules is hindered by the lack of
a commercially available aprepitant oral liquid formulation in many jurisdictions including …

• Pain is an unpleasant sensory experience and an emotional experience associated with
actual or potential tissue damage. Pain is the subjective experience of the patient.

Introduction: Aprepitant, a moderate CYP3A4 inhibitor, is recommended for prevention of
chemotherapy-induced nausea and vomiting. Little information is available regarding the …

Despite concerted functional genomic efforts to understand the complex phenotype of
ionizing radiation (IR) resistance, a genome sequence cannot predict whether a cell is IR-resistant …